Sanofi Eyes India For Phase III Dengue Vaccine Study
This article was originally published in PharmAsia News
Executive Summary
Sanofi Pasteur's late-stage dengue vaccine continues to progress across territories with the company now planning a Phase III Indian study in subjects from a range of age groups.